Skip to main content
Top
Published in: Journal of Neuroinflammation 1/2012

Open Access 01-12-2012 | Research

Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infection

Authors: Stephen J Hopkins, Catherine J McMahon, Navneet Singh, James Galea, Margaret Hoadley, Sylvia Scarth, Hiren Patel, Andy Vail, Sharon Hulme, Nancy J Rothwell, Andrew T King, Pippa J Tyrrell

Published in: Journal of Neuroinflammation | Issue 1/2012

Login to get access

Abstract

Background

Cytokines and cytokine receptor concentrations increase in plasma and cerebrospinal fluid (CSF) of patients following subarachnoid haemorrhage (SAH). The relationship between plasma and CSF cytokines, and factors affecting this, are not clear.

Methods

To help define the relationship, paired plasma and cerebrospinal fluid (CSF) samples were collected from patients subject to ventriculostomy. Concentrations of key inflammatory cytokines, interleukin (IL)-1ß, IL-1 receptor antagonist (IL-1Ra), IL-1 receptor 2, IL-6, IL-8, IL-10, tumour necrosis factor (TNF)-α, and TNF receptors (TNF-R) 1 and 2 were determined by immunoassay of CSF and plasma from 21 patients, where samples were available at three or more time points.

Results

Plasma concentrations of IL-1ß, IL-1Ra, IL-10, TNF-α and TNF-R1 were similar to those in CSF. Plasma TNF-R2 and IL-1R2 concentrations were higher than in CSF. Concentrations of IL-8 and IL-6 in CSF were approximately10 to 1,000-fold higher than in plasma. There was a weak correlation between CSF and plasma IL-8 concentrations (r = 0.26), but no correlation for IL-6. Differences between the central and peripheral pattern of IL-6 were associated with episodes of ventriculostomy-related infection (VRI). A VRI was associated with CSF IL-6 >10,000 pg/mL (P = 0.0002), although peripheral infection was not significantly associated with plasma IL-6.

Conclusions

These data suggest that plasma cytokine concentrations cannot be used to identify relative changes in the CSF, but that measurement of CSF IL-6 could provide a useful marker of VRI.
Literature
1.
go back to reference Denes A, Thornton P, Rothwell NJ, Allan SM: Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun 2010, 24:708–723.CrossRefPubMed Denes A, Thornton P, Rothwell NJ, Allan SM: Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun 2010, 24:708–723.CrossRefPubMed
3.
go back to reference Osuka K, Suzuki Y, Tanazawa T, Hattori K, Yamamoto N, Takayasu M, Shibuya M, Yoshida J: Interleukin-6 and development of vasospasm after subarachnoid haemorrhage. Acta Neurochir 1998, 140:943–951.CrossRefPubMed Osuka K, Suzuki Y, Tanazawa T, Hattori K, Yamamoto N, Takayasu M, Shibuya M, Yoshida J: Interleukin-6 and development of vasospasm after subarachnoid haemorrhage. Acta Neurochir 1998, 140:943–951.CrossRefPubMed
4.
go back to reference Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S, Fritzinger M, Horn P, Vajkoczy P, Kreisel S, Brunner J, Schmiedek P, Hennerici M: Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 2001, 70:534–537.CrossRefPubMedPubMedCentral Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S, Fritzinger M, Horn P, Vajkoczy P, Kreisel S, Brunner J, Schmiedek P, Hennerici M: Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 2001, 70:534–537.CrossRefPubMedPubMedCentral
5.
go back to reference Hendryk S, Jarzab B, Josko J: Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuroendocrinology Letters 2004, 25:141–147.PubMed Hendryk S, Jarzab B, Josko J: Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuroendocrinology Letters 2004, 25:141–147.PubMed
6.
go back to reference Kwon KY, Jeon BC: Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. J Korean Med Sci 2001, 16:774–780.CrossRefPubMedPubMedCentral Kwon KY, Jeon BC: Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. J Korean Med Sci 2001, 16:774–780.CrossRefPubMedPubMedCentral
7.
go back to reference Smith CJ, Emsley CA, Gavin CM, Georgiou RF, Vail A, Barberan EM, del Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ, Tyrrell PJ: Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 2004, 4:2.CrossRefPubMed Smith CJ, Emsley CA, Gavin CM, Georgiou RF, Vail A, Barberan EM, del Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ, Tyrrell PJ: Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 2004, 4:2.CrossRefPubMed
8.
go back to reference Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M: Proinflammatory cytokines in serum of patients with acute cerebral-ischemia - kinetics of secretion and relation to the extent of brain-damage and outcome of disease. J Neurol Sci 1994, 122:135–139.CrossRefPubMed Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M: Proinflammatory cytokines in serum of patients with acute cerebral-ischemia - kinetics of secretion and relation to the extent of brain-damage and outcome of disease. J Neurol Sci 1994, 122:135–139.CrossRefPubMed
9.
go back to reference Emsley H, Smith C, Gavin C, Georgiou R, Vail A, Barberan E, Illingworth K, Scarth S, Wickramasinghe V, Hoadley M, Rothwell NJ, Tyrrell PJ, Hopkins SJ: Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurol 2007, 7:5.CrossRefPubMedPubMedCentral Emsley H, Smith C, Gavin C, Georgiou R, Vail A, Barberan E, Illingworth K, Scarth S, Wickramasinghe V, Hoadley M, Rothwell NJ, Tyrrell PJ, Hopkins SJ: Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurol 2007, 7:5.CrossRefPubMedPubMedCentral
10.
go back to reference McMahon CJ, Hopkins S, Vail A, King AT, Smith D, Illingworth KJ, Clark S: Rothwell NJ. Inflammation as a predictor for delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. J Neurointerv Surg, Tyrrell PJ; 2012 Oct 11. [Epub ahead of print] McMahon CJ, Hopkins S, Vail A, King AT, Smith D, Illingworth KJ, Clark S: Rothwell NJ. Inflammation as a predictor for delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. J Neurointerv Surg, Tyrrell PJ; 2012 Oct 11. [Epub ahead of print]
11.
go back to reference Emsley HCA, Smith CJ, Georgiou RF, Vail A, Hopkins SJ, Rothwell NJ, Tyrrell PJ, Investigators ftI-riAS: A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry 2005, 76:1366–1372.CrossRefPubMedPubMedCentral Emsley HCA, Smith CJ, Georgiou RF, Vail A, Hopkins SJ, Rothwell NJ, Tyrrell PJ, Investigators ftI-riAS: A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry 2005, 76:1366–1372.CrossRefPubMedPubMedCentral
12.
go back to reference Emsley HCA, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, Hallenbeck JM, del Zoppo GJ, Rothwell NJ, Tyrrell PJ, Hopkins SJ: An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 2003, 139:93–101.CrossRefPubMed Emsley HCA, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, Hallenbeck JM, del Zoppo GJ, Rothwell NJ, Tyrrell PJ, Hopkins SJ: An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 2003, 139:93–101.CrossRefPubMed
13.
go back to reference Kikuchi T, Okuda Y, Kaito N, Abe T: Cytokine production in cerebrospinal fluid after subarachnoid hemorrhage. Neurol Res 1995, 17:106–108.CrossRefPubMed Kikuchi T, Okuda Y, Kaito N, Abe T: Cytokine production in cerebrospinal fluid after subarachnoid hemorrhage. Neurol Res 1995, 17:106–108.CrossRefPubMed
14.
go back to reference Mathiesen T, Edner G, Ulfarsson E, Andersson B: Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg 1997, 87:215–220.CrossRefPubMed Mathiesen T, Edner G, Ulfarsson E, Andersson B: Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg 1997, 87:215–220.CrossRefPubMed
15.
go back to reference Gruber A, Rossler K, Graninger W, Donner A, Illievich MU, Czech T: Ventricular cerebrospinal fluid and serum concentrations of sTNFR-I, IL-1ra, and IL-6 after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2000, 12:297–306.CrossRefPubMed Gruber A, Rossler K, Graninger W, Donner A, Illievich MU, Czech T: Ventricular cerebrospinal fluid and serum concentrations of sTNFR-I, IL-1ra, and IL-6 after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2000, 12:297–306.CrossRefPubMed
16.
go back to reference Gaetani P, Tartara F, Pignatti P, Tancioni F, Baena RRY, De Benedetti F: Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 1998, 20:337–342.CrossRefPubMed Gaetani P, Tartara F, Pignatti P, Tancioni F, Baena RRY, De Benedetti F: Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 1998, 20:337–342.CrossRefPubMed
17.
go back to reference Mathiesen T, Andersson B, Loftenius A, von Holst H: Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg 1993, 78:562–567.CrossRefPubMed Mathiesen T, Andersson B, Loftenius A, von Holst H: Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg 1993, 78:562–567.CrossRefPubMed
18.
go back to reference Graetz D, Nagel A, Schlenk F, Sakowitz O, Vajkoczy P, Sarrafzadeh A: High ICP as trigger of proinflammatory IL-6 cytokine activation in aneurysmal subarachnoid hemorrhage. Neurol Res 2010, 32:728–735.CrossRefPubMed Graetz D, Nagel A, Schlenk F, Sakowitz O, Vajkoczy P, Sarrafzadeh A: High ICP as trigger of proinflammatory IL-6 cytokine activation in aneurysmal subarachnoid hemorrhage. Neurol Res 2010, 32:728–735.CrossRefPubMed
19.
go back to reference Mellergard P, Aneman O, Sjogren F, Pettersson P, Hillman J: Changes in extracellular concentrations of some cytokines, chemokines, and neurotrophic factors after insertion of intracerebral microdialysis catheters in neurosurgical patients. Neurosurgery 2008, 62:151–157.CrossRefPubMed Mellergard P, Aneman O, Sjogren F, Pettersson P, Hillman J: Changes in extracellular concentrations of some cytokines, chemokines, and neurotrophic factors after insertion of intracerebral microdialysis catheters in neurosurgical patients. Neurosurgery 2008, 62:151–157.CrossRefPubMed
20.
go back to reference Dhar R, Diringer M: The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care 2008, 8:404–412.CrossRefPubMedPubMedCentral Dhar R, Diringer M: The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care 2008, 8:404–412.CrossRefPubMedPubMedCentral
21.
go back to reference Shenhar-Tsarfaty S, Assayag EB, Bova I, Shopin L, Fried M, Berliner S, Shapira I, Bornstein NM: Interleukin-6 as an early predictor for one-year survival following an ischaemic stroke/transient ischaemic attack. Int J Stroke 2010, 5:16–20.CrossRefPubMed Shenhar-Tsarfaty S, Assayag EB, Bova I, Shopin L, Fried M, Berliner S, Shapira I, Bornstein NM: Interleukin-6 as an early predictor for one-year survival following an ischaemic stroke/transient ischaemic attack. Int J Stroke 2010, 5:16–20.CrossRefPubMed
22.
go back to reference Whiteley W, Jackson C, Lewis S, Lowe G, Rumley A, Sandercock P, Wardlaw J, Dennis M, Sudlow C: Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med 2009, 6:e1000145.CrossRefPubMedPubMedCentral Whiteley W, Jackson C, Lewis S, Lowe G, Rumley A, Sandercock P, Wardlaw J, Dennis M, Sudlow C: Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med 2009, 6:e1000145.CrossRefPubMedPubMedCentral
23.
go back to reference Woiciechowsky C, Schöning B, Cobanov J, Lanksch WR, Volk H-D, Döcke W-D: Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients. J Trauma 2002, 52:339–345.CrossRefPubMed Woiciechowsky C, Schöning B, Cobanov J, Lanksch WR, Volk H-D, Döcke W-D: Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients. J Trauma 2002, 52:339–345.CrossRefPubMed
24.
go back to reference Arend WP, Maseoni RJ: Characteristics of bacterial lipopolysaccharide induction of interleukin 1 synthesis and secretion by human monocytes. Clin Exp Immunol 1986, 64:656–664.PubMedPubMedCentral Arend WP, Maseoni RJ: Characteristics of bacterial lipopolysaccharide induction of interleukin 1 synthesis and secretion by human monocytes. Clin Exp Immunol 1986, 64:656–664.PubMedPubMedCentral
25.
go back to reference Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP: High circulating levels of interleukin-6 in patients with septic shock - Evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 1991, 91:23–29.CrossRefPubMed Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP: High circulating levels of interleukin-6 in patients with septic shock - Evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 1991, 91:23–29.CrossRefPubMed
26.
go back to reference Helfgott DC, Tatter SB, Santhanam U, Clarick RH, Bhardwaj N, May LT, Sehgal B: Multiple forms of IFN-á2 /IL-6 in plasma and body fluids during acute bacterial infection. J Immunol 1989, 142:948–953.PubMed Helfgott DC, Tatter SB, Santhanam U, Clarick RH, Bhardwaj N, May LT, Sehgal B: Multiple forms of IFN-á2 /IL-6 in plasma and body fluids during acute bacterial infection. J Immunol 1989, 142:948–953.PubMed
27.
go back to reference Jirik FR, Poder TJ, Hirano T, Kishimoto T, Loskutoff DJ, Carson DA, Lotz DA: Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 1989, 142:144–147.PubMed Jirik FR, Poder TJ, Hirano T, Kishimoto T, Loskutoff DJ, Carson DA, Lotz DA: Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 1989, 142:144–147.PubMed
28.
go back to reference Emsley HCA, Hopkins SJ: Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol 2008, 7:341–353.CrossRefPubMed Emsley HCA, Hopkins SJ: Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol 2008, 7:341–353.CrossRefPubMed
29.
go back to reference McColl BW, Rothwell NJ, Allan SM: Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J Neurosci 2007, 27:4403–4412.CrossRefPubMed McColl BW, Rothwell NJ, Allan SM: Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J Neurosci 2007, 27:4403–4412.CrossRefPubMed
30.
go back to reference Fong Y, Moldawer LL, Marano MA, Wei H, Tatter SB, Clarick RH, Santhanam U, Sherris D, May LT, Sehgal PB, Lowry SF: Endotoxemia elicits increasted circulating 2-IFN /IL-6 in man. J Immunol 1989, 142:2321–2324.PubMed Fong Y, Moldawer LL, Marano MA, Wei H, Tatter SB, Clarick RH, Santhanam U, Sherris D, May LT, Sehgal PB, Lowry SF: Endotoxemia elicits increasted circulating 2-IFN /IL-6 in man. J Immunol 1989, 142:2321–2324.PubMed
31.
go back to reference Hack CE, Degroot ER, Feltbersma RJF, Niujens JH, Vanschijndel RJMS, Eerenbergbelmer AJM, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood 1989, 74:1704–1710.PubMed Hack CE, Degroot ER, Feltbersma RJF, Niujens JH, Vanschijndel RJMS, Eerenbergbelmer AJM, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood 1989, 74:1704–1710.PubMed
32.
go back to reference Foulon W, Van Liedekerke D, Demanet C, Decatte L, Dewaele M, Naessens A: Markers of infection and their relationship to preterm delivery. Am J Perinatol 1995, 12:208–211.CrossRefPubMed Foulon W, Van Liedekerke D, Demanet C, Decatte L, Dewaele M, Naessens A: Markers of infection and their relationship to preterm delivery. Am J Perinatol 1995, 12:208–211.CrossRefPubMed
33.
go back to reference Moscovitz H, Shofer F, Mignott H, Behrman A, Kilpatrick L: Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Crit Care Med 1994, 22:1102–1107.CrossRefPubMed Moscovitz H, Shofer F, Mignott H, Behrman A, Kilpatrick L: Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Crit Care Med 1994, 22:1102–1107.CrossRefPubMed
34.
go back to reference Rego MAC, Martinez FE, Elias J, Mussi-Pinhata MM: Diagnostic value of interleukin-6 and C-reactive protein on early onset bacterial infection in preterm neonates with respiratory distress. J Perinat Med 2010, 38:527–533.CrossRefPubMed Rego MAC, Martinez FE, Elias J, Mussi-Pinhata MM: Diagnostic value of interleukin-6 and C-reactive protein on early onset bacterial infection in preterm neonates with respiratory distress. J Perinat Med 2010, 38:527–533.CrossRefPubMed
35.
go back to reference López-Cortés LF, Marquez-Arbizu R, Jimenez-Jimenez LM, Jimenez-Mejías E, Caballero-Granado FJ, Rey-Romero C, Polaina M, Pachón J: Cerebrospinal fluid tumor necrosis factor-[alpha], interleukin-1[beta], interleukin-6, and interleukin-8 as diagnostic markers of cerebrospinal fluid infection in neurosurgical patients. Crit Care Med 2000, 28:215–219.CrossRefPubMed López-Cortés LF, Marquez-Arbizu R, Jimenez-Jimenez LM, Jimenez-Mejías E, Caballero-Granado FJ, Rey-Romero C, Polaina M, Pachón J: Cerebrospinal fluid tumor necrosis factor-[alpha], interleukin-1[beta], interleukin-6, and interleukin-8 as diagnostic markers of cerebrospinal fluid infection in neurosurgical patients. Crit Care Med 2000, 28:215–219.CrossRefPubMed
36.
go back to reference Baumeister FAM, Pohl-Koppe A, Hofer M, Kim JO, Weiss M: IL-6 in CSF during ventriculitis in preterm infants with posthemorrhagic hydrocephalus. Infection 2000, 28:234–236.CrossRefPubMed Baumeister FAM, Pohl-Koppe A, Hofer M, Kim JO, Weiss M: IL-6 in CSF during ventriculitis in preterm infants with posthemorrhagic hydrocephalus. Infection 2000, 28:234–236.CrossRefPubMed
37.
go back to reference Schade RP, Schinkel J, Roelandse FWC, Geskus RB, Visser LG, van Dijk MC, Voormolen JHC, van Pelt H, Kuijper EJ: Lack of value of routine analysis of cerebrospinal fluid for prediction and diagnosis of external drainage–related bacterial meningitis. J Neurosurg 2006, 104:101–108.CrossRefPubMed Schade RP, Schinkel J, Roelandse FWC, Geskus RB, Visser LG, van Dijk MC, Voormolen JHC, van Pelt H, Kuijper EJ: Lack of value of routine analysis of cerebrospinal fluid for prediction and diagnosis of external drainage–related bacterial meningitis. J Neurosurg 2006, 104:101–108.CrossRefPubMed
38.
go back to reference Schoch B, Regel JP, Nierhaus A, Wichert M, Mueller OM, Sandalcioglu IE, Mann K, Stolke D: Predictive value of intrathecal interleukin-6 for ventriculostomy-related infection. Cen Eur Neurosurg 2008, 69:80–86. Schoch B, Regel JP, Nierhaus A, Wichert M, Mueller OM, Sandalcioglu IE, Mann K, Stolke D: Predictive value of intrathecal interleukin-6 for ventriculostomy-related infection. Cen Eur Neurosurg 2008, 69:80–86.
39.
go back to reference Bota DP, Lefranc F, Vilallobos HR, Brimioulle S, Vincent J-L: Ventriculostomy-related infections in critically ill patients: a 6-year experience. J Neurosurg 2005, 103:468–472.CrossRefPubMed Bota DP, Lefranc F, Vilallobos HR, Brimioulle S, Vincent J-L: Ventriculostomy-related infections in critically ill patients: a 6-year experience. J Neurosurg 2005, 103:468–472.CrossRefPubMed
40.
go back to reference Prabhu VC, Kaufman HH, Voelker JL, Aronoff SC, Niewiadomska-Bugaj M, Mascaro S, Hobbs GR: Prophylactic antibiotics with intracranial pressure monitors and external ventricular drains: a review of the evidence. Surg Neurol 1999, 52:226–237.CrossRefPubMed Prabhu VC, Kaufman HH, Voelker JL, Aronoff SC, Niewiadomska-Bugaj M, Mascaro S, Hobbs GR: Prophylactic antibiotics with intracranial pressure monitors and external ventricular drains: a review of the evidence. Surg Neurol 1999, 52:226–237.CrossRefPubMed
Metadata
Title
Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infection
Authors
Stephen J Hopkins
Catherine J McMahon
Navneet Singh
James Galea
Margaret Hoadley
Sylvia Scarth
Hiren Patel
Andy Vail
Sharon Hulme
Nancy J Rothwell
Andrew T King
Pippa J Tyrrell
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2012
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-9-255

Other articles of this Issue 1/2012

Journal of Neuroinflammation 1/2012 Go to the issue